Horie Hitoshi, Yoshida Hiromu, Matsuura Kumiko, Miyazawa Miwako, Wakabayashi Kengo, Nomoto Akio, Hashizume So
Japan Poliomyelitis Research Institute, Higashimurayama-shi, Tokyo, Japan.
J Med Virol. 2002 Nov;68(3):445-51. doi: 10.1002/jmv.10224.
Type 1, 2, and 3 vaccine-derived polioviruses were isolated from a sewage disposal plant located downstream of the Oyabe River in Toyama Prefecture, Japan, between October 1993 and September 1995. Neurovirulence was analyzed in 13 type 1 vaccine-derived strains, using mutant analysis by polymerase chain reaction and restriction enzyme cleavage (MAPREC). Nine strains (69%) were estimated to have marked neurovirulence. Some of the neutralizing antigenic sites, temperature sensitivity, and plaque-forming ability of two virulent vaccine-derived poliovirus strains were similar to Mahoney strain. The neutralizing activity of human sera obtained after oral poliomyelitis vaccine (OPV) administration against one of the virulent vaccine-derived polioviruses was examined. Although all human sera showed sufficient neutralizing activity for the prevention of poliomyelitis by vaccine-derived poliovirus strains, a lower titer than that against Sabin type 1 strain was observed. Vaccination against virulent vaccine-derived poliovirus will be effective. However, the environmental presence of viruses that have properties similar to those Mahoney strain is a threat. The introduction of inactivated poliovirus vaccine (IPV), and well-maintained herd immunity, together with reinforced environmental surveillance is important for the final phase of the polio eradication program by the World Health Organization (WHO).
1993年10月至1995年9月期间,在日本富山县小矢部川下游的一个污水处理厂分离出了1型、2型和3型疫苗衍生脊髓灰质炎病毒。使用聚合酶链反应和限制性内切酶切割突变分析(MAPREC)对13株1型疫苗衍生毒株进行了神经毒力分析。估计有9株(69%)具有明显的神经毒力。两株强毒疫苗衍生脊髓灰质炎病毒株的一些中和抗原位点、温度敏感性和蚀斑形成能力与Mahoney株相似。检测了口服脊髓灰质炎疫苗(OPV)接种后获得的人血清对其中一株强毒疫苗衍生脊髓灰质炎病毒的中和活性。尽管所有的人血清对疫苗衍生脊髓灰质炎病毒株预防脊髓灰质炎都显示出足够的中和活性,但观察到其滴度低于对Sabin 1型毒株的滴度。针对强毒疫苗衍生脊髓灰质炎病毒进行疫苗接种将是有效的。然而,具有与Mahoney株相似特性的病毒在环境中的存在是一种威胁。引入灭活脊髓灰质炎疫苗(IPV)、维持良好的群体免疫以及加强环境监测对于世界卫生组织(WHO)脊髓灰质炎根除计划的最后阶段至关重要。